128 related articles for article (PubMed ID: 28562165)
21. Epstein-Barr virus upregulates phosphorylated heat shock protein 27 kDa in carcinoma cells using the phosphoinositide 3-kinase/Akt pathway.
Fukagawa Y; Nishikawa J; Kuramitsu Y; Iwakiri D; Takada K; Imai S; Satake M; Okamoto T; Fujimoto M; Okita K; Nakamura K; Sakaida I
Electrophoresis; 2008 Aug; 29(15):3192-200. PubMed ID: 18604870
[TBL] [Abstract][Full Text] [Related]
22. Cell-cycle regulators, bcl-2 and NF-kappaB in Epstein-Barr virus-positive gastric carcinomas.
Chang MS; Lee HS; Jung EJ; Kim CW; Lee BL; Kim WH
Int J Oncol; 2005 Nov; 27(5):1265-72. PubMed ID: 16211221
[TBL] [Abstract][Full Text] [Related]
23. Classification of Epstein-Barr virus-positive gastric cancers by definition of DNA methylation epigenotypes.
Matsusaka K; Kaneda A; Nagae G; Ushiku T; Kikuchi Y; Hino R; Uozaki H; Seto Y; Takada K; Aburatani H; Fukayama M
Cancer Res; 2011 Dec; 71(23):7187-97. PubMed ID: 21990320
[TBL] [Abstract][Full Text] [Related]
24. Implication of Leptin-Signaling Proteins and Epstein-Barr Virus in Gastric Carcinomas.
Choi E; Byeon SJ; Kim SH; Lee HJ; Kwon HJ; Ahn H; Kim DH; Chang MS
PLoS One; 2015; 10(7):e0130839. PubMed ID: 26147886
[TBL] [Abstract][Full Text] [Related]
25. [Gastric carcinoma is the most frequent Epstein-Barr virus-associated malignancy].
Boysen T; Friborg J
Ugeskr Laeger; 2013 Nov; 175(47A):. PubMed ID: 25353091
[TBL] [Abstract][Full Text] [Related]
26. Highly Efficient CRISPR/Cas9-Mediated Cloning and Functional Characterization of Gastric Cancer-Derived Epstein-Barr Virus Strains.
Kanda T; Furuse Y; Oshitani H; Kiyono T
J Virol; 2016 May; 90(9):4383-93. PubMed ID: 26889033
[TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr Virus-associated Gastric Cancer and Potential Mechanisms of Oncogenesis.
Morales-Sanchez A; Fuentes-Panana EM
Curr Cancer Drug Targets; 2017; 17(6):534-554. PubMed ID: 27677953
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus and microsatellite instability in gastric carcinogenesis.
Chang MS; Lee HS; Kim HS; Kim SH; Choi SI; Lee BL; Kim CW; Kim YI; Yang M; Kim WH
J Pathol; 2003 Apr; 199(4):447-52. PubMed ID: 12635135
[TBL] [Abstract][Full Text] [Related]
29. SALL4, a novel marker for human gastric carcinogenesis and metastasis.
Zhang L; Xu Z; Xu X; Zhang B; Wu H; Wang M; Zhang X; Yang T; Cai J; Yan Y; Mao F; Zhu W; Shao Q; Qian H; Xu W
Oncogene; 2014 Nov; 33(48):5491-500. PubMed ID: 24276240
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus-positive gastric cancer: a distinct molecular subtype of the disease?
Jácome AA; Lima EM; Kazzi AI; Chaves GF; Mendonça DC; Maciel MM; Santos JS
Rev Soc Bras Med Trop; 2016 Apr; 49(2):150-7. PubMed ID: 27192582
[TBL] [Abstract][Full Text] [Related]
31. Radiation-induced Epstein-Barr virus reactivation in gastric cancer cells with latent EBV infection.
Nandakumar A; Uwatoko F; Yamamoto M; Tomita K; Majima HJ; Akiba S; Koriyama C
Tumour Biol; 2017 Jul; 39(7):1010428317717718. PubMed ID: 28675108
[TBL] [Abstract][Full Text] [Related]
32. Testican-1-mediated epithelial-mesenchymal transition signaling confers acquired resistance to lapatinib in HER2-positive gastric cancer.
Kim HP; Han SW; Song SH; Jeong EG; Lee MY; Hwang D; Im SA; Bang YJ; Kim TY
Oncogene; 2014 Jun; 33(25):3334-41. PubMed ID: 23873022
[TBL] [Abstract][Full Text] [Related]
33. CT appearance of Epstein-Barr virus-associated gastric carcinoma.
Maeda E; Akahane M; Uozaki H; Kato N; Hayashi N; Fukayama M; Ohtomo K
Abdom Imaging; 2009; 34(5):618-25. PubMed ID: 18668190
[TBL] [Abstract][Full Text] [Related]
34. Meta-analysis of the relationship between Epstein-Barr virus infection and clinicopathological features of patients with gastric carcinoma.
Li S; Du H; Wang Z; Zhou L; Zhao X; Zeng Y
Sci China Life Sci; 2010 Apr; 53(4):524-30. PubMed ID: 20596921
[TBL] [Abstract][Full Text] [Related]
35. Expression profile of latent and lytic transcripts of epstein-barr virus in patients with gastroduodenal diseases: a study from northern India.
Shukla SK; Prasad KN; Tripathi A; Ghoshal UC; Krishnani N; Husain N
J Med Virol; 2012 Aug; 84(8):1289-97. PubMed ID: 22711358
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus latent membrane protein 2A suppresses the expression of HER2 via a pathway involving TWIST and YB-1 in Epstein-Barr virus-associated gastric carcinomas.
Zhang YW; Zhao XX; Tan C; Zhang ZG; Jiang Y; Chen JN; Wei HB; Xue L; Li HG; Du H; Shao CK
Oncotarget; 2015 Jan; 6(1):207-20. PubMed ID: 25402957
[TBL] [Abstract][Full Text] [Related]
37. Correlation Between Infection Status of Epstein-Barr Virus and
Na SJ; Park HL; O JH; Lee SY; Song KY; Kim SH
In Vivo; 2017; 31(4):749-753. PubMed ID: 28652452
[TBL] [Abstract][Full Text] [Related]
38. Ganciclovir augments the lytic induction and apoptosis induced by chemotherapeutic agents in an Epstein-Barr virus-infected gastric carcinoma cell line.
Ji Jung E; Mie Lee Y; Lan Lee B; Soo Chang M; Ho Kim W
Anticancer Drugs; 2007 Jan; 18(1):79-85. PubMed ID: 17159505
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell metastasis and invasion by targeting long non-coding RNA LOC553103.
He B; Li W; Wu Y; Wei F; Gong Z; Bo H; Wang Y; Li X; Xiang B; Guo C; Liao Q; Chen P; Zu X; Zhou M; Ma J; Li X; Li Y; Li G; Xiong W; Zeng Z
Cell Death Dis; 2016 Sep; 7(9):e2353. PubMed ID: 27584792
[TBL] [Abstract][Full Text] [Related]
40. Slow Progression of Poorly Differentiated Gastric Carcinoma Associated with Epstein-Barr Virus Infection: 12-year Follow-up.
Yoza R; Ueda Y; Sakuma Y; Minami N; Takahashi K; Minamiguchi S; Haga H; Chiba T
Intern Med; 2015; 54(12):1505-8. PubMed ID: 26073239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
